Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-۳ (TIM-۳)

Publish Year: 1395
نوع سند: مقاله ژورنالی
زبان: English
View: 191

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-19-11_008

تاریخ نمایه سازی: 30 مهر 1400

Abstract:

Objective(s): As T-cell immunoglobulin and mucin domain ۳ (TIM-۳) is an immune regulatory molecule; its blocking or stimulating could alter the pattern of immune response towards a desired condition. Based on the unique features of nanobodies, we aimed to construct an anti-TIM-۳ nanobody as an appropriate tool for manipulating immune responses for future therapeutic purposes. Materials and Methods:We immunized a camel with TIM-۳ antigen and then, synthesized a VHH phagemid library from its B cell’s transcriptome using nested PCR. Library selection against TIM-۳antigen was performed in three rounds of panning. Using phage-ELISA, the most reactive colonies were selected for sub-cloning in soluble protein expression vectors. The Nanobody was purified and confirmed with a nickel-nitrilotriacetic acid (Ni-NTA) column, SDS-PAGE and Western blotting. A flowcytometric analysis was performed to analyze the binding and biologic activities of theTIM-۳ specific nanobody with TIM-۳ expressing HL-۶۰ and HEK cell lines. Results:Specific ۱۵kD band representing for nanobody was observed on the gel and confirmed with Western blotting. The nanobody showed significant specific immune-reactivity against TIM-۳ with a relatively high binding affinity. The nanobody significantly suppressed the proliferation of TIM-۳ expressing HL-۶۰ cell line. Conclusion: Finally, we successfully prepared a functional anti-humanTIM-۳ specific nanobody with a high affinity and an anti-proliferative activity on an AML cell line in vitro.

Keywords:

antibody , Heavy chain antibody , Nanobody , Phage display , T-cell immunoglobulin and mucin domain ۳

Authors

Vida Homayouni

Immunology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Mazdak Ganjalikhani-hakemi

Immunology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abbas Rezaei

Immunology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Hossein Khanahmad

Genetic Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Mahdi Behdani

Biotechnology Research Center, Biotechnology Department, Venom & Bio-therapeutics Molecules Lab, Pasteur Institute of Iran, Tehran, Iran

Fatemeh Kazemi Lomedasht

Biotechnology Research Center, Biotechnology Department, Venom & Bio-therapeutics Molecules Lab, Pasteur Institute of Iran, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Kane LP. T cell Ig and mucin domain proteins and ...
  • Umetsu DT, Umetsu SE, Freeman GJ, DeKruyff RH.TIM gene family ...
  • Tong D, Zhou Y, Chen W, Deng Y, Li L, ...
  • Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, ...
  • Tang ZH, Liang S, Potter J, Jiang X, Mao HQ, ...
  • Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, ...
  • Nagahara K, Arikawa T, Oomizu S, Kontani K, Nobumoto A, ...
  • Wherry EJ. T cell exhaustion. Nat Immunol ۲۰۱۱; ۱۲:۴۹۲-۴۹۹ ...
  • Le Mercier I, Lines JL, Noelle RJ. Beyond CTLA-۴ and ...
  • Ngiow SF, von Scheidt B, Akiba H, Yagita H, Teng ...
  • Baghdadi M, Takeuchi S, Wada H, Seino K. Blocking monoclonal ...
  • Jin HT, Anderson AC, Tan WG, West EE, Ha SJ, ...
  • Dietze KK, Zelinskyy G, Liu J, Kretzmer F, Schimmer S, ...
  • Sakuishi K, , Apetoh L, Sullivan JM, Blazar BR, Kuchroo ...
  • Sakuishi K, Ngiow SF, Sullivan JM, Teng MW, Kuchroo VK, ...
  • Gonçalves Silva I, Gibbs BF, Bardelli M, Varani L, Sumbayev ...
  • Anderson AC. Tim-۳, a negative regulator of anti-tumor immunity. Curr ...
  • Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH. TIM genes:a ...
  • Siontorou CG. Nanobodies as novel agents for disease diagnosis and ...
  • Bell A, Wang ZJ, Arbabi-Ghahroudi M, Chang TA, Durocher Y, ...
  • Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, ...
  • Yardehnavi N, Behdani M, Bagheri KP, Mahmoodzadeh A, Khanahmad H, ...
  • Muyldermans S. Single domain camel antibodies: current status. J Biotechnol ...
  • DeKruyff RH, Bu X, Ballesteros A, Santiago C, Chim YL, ...
  • Cao E, Zang X, Ramagopal UA, Mukhopadhaya A, Fedorov A, ...
  • Chiba S, Chiba S, Baghdadi M, Akiba H, Yoshiyama H, ...
  • Clayton KL, Haaland MS, Douglas-Vail MB, Mujib S, Chew GM, ...
  • Sada-Ovalle I, Ocaña-Guzman R, Pérez-Patrigeón S, Chávez-Galán L, Sierra-Madero J, ...
  • Sakuishi K, Ngiow SF, Sullivan JM, Teng MW, Kuchroo VK, ...
  • Baghdadi M, Takeuchi S, Wada H, Seino K.Blocking monoclonal antibodies ...
  • Chiba S, Baghdadi M, Akiba H, Yoshiyama H, Kinoshita I, ...
  • Ngiow SF, von Scheidt B,Akiba H, Yagita H, Teng MWL, ...
  • Leone RD, Lo YC, Powell JD. A۲aR antagonists: Next generation ...
  • Chames P, Van Regenmortel M, Weiss E, Baty D.Therapeutic antibodies: ...
  • Omidfar K, Rasaee MJ, Modjtahedi H, Forouzandeh M, Taghikhani M, ...
  • Behdani M, Zeinali S, Khanahmad H, Karimipour M, Asadzadeh N, ...
  • Ahmadvand D, Rasaee MJ,Rahbarizadeh F, Kontermann RE, Sheikholislami F. Cell ...
  • Abul Abbas AHL, Shiv Pillai. Cellular and Molecular Immunology. ۲۰۱۵; ...
  • Roovers RC, Laeremans T, Huang L, De Taeye S, Verkleij ...
  • نمایش کامل مراجع